| Net loss | -816.34K |
| Depreciation and amortization | 282.75K |
| Stock based compensation | 579 |
| Provision for doubtful accounts and sales returns and allowances | |
| Deferred taxes | 0 |
| Accounts receivable | 871.41K |
| Inventories | -184.02K |
| Income tax receivable | -5.4K |
| Other current assets | |
| Accounts payable | -63.87K |
| Deferred revenue | |
| Other accrued liabilities | |
| Net cash provided by operating activities | |
| Capital expenditures | -8.6K |
| Net cash used in investing activities | |
| Net cash provided by financing activities | |
| Net increase (decrease) in cash and cash equivalents | -339.24K |
| Cash and cash equivalents at beginning of period | 1.7M |
| Cash and cash equivalents at end of period | 1.36M |